Single-use bioreactors (SUBs) are emerging as a major technology in the field of pharmaceuticals. SUBs have become an established addition to today’s biotechnology manufacturing facilities, as they are widely being used in both the pharmaceutical and biopharmaceutical industry. Pharma companies use single-use bioreactors for cell harvesting, filtration, purification, virus inactivation, and media and buffer preparation, among others. They are mostly suitable for biopharmaceutical applications. Thus, there is an increase in demand for SUBs worldwide.
Market Dynamics:
Increase in adoption of single-use bioreactors, rapid adoption of single-use technologies, growing burden of chronic and infectious disease, rising demand for biologics, and outbreak of COVID-19 are major factors expected to aid in the growth of the global single-use bioreactor market.
For instance, in November 2022, Juvena Therapeutics, Inc. raised $41 million in an oversubscribed Series A, bringing its total funding to $50 million. The new funding will power the expansion of Juvena’s drug discovery platform and advance the company’s biologics pipeline targeting chronic and age-related diseases. Moreover, in May 2022, RD-Biotech and Pall Corporation teamed up to supply single-use solutions and purification technology to support the manufacture of industrially relevant volumes of GMP-grade pDNA.
Key features of the study:
- This report provides in-depth analysis of the global single-use bioreactor market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global single-use bioreactor market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Sartorius AG, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, OmniBRx Biotechnologies, and Danaher Corporation (Pall Corporation), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global single-use bioreactor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single-use bioreactor market.
Detailed Segmentation:
- Global Single-Use Bioreactor Market By Product:
- Single-use Bioreactor Systems
- Media Bags
- Filtration Assemblies
- Other Products
- Global Single-Use Bioreactor Market By Cell Type:
- Mammalian Cell
- Bacteria
- Yeast
- Other Cell Types
- Global Single-Use Bioreactor Market By Molecule Type:
- Vaccines
- Monoclonal Antibodies
- Stem Cells
- Recombinant Proteins
- Other Molecule Types
- Global Single-Use Bioreactor Market By End User:
- Pharmaceutical and Biopharmaceutical Industries
- Contract Research Organizations (CRO)
- Other End Users
- Global Single-Use Bioreactor Market By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
- Company Profiles:
- Sartorius AG
- OmniBRx Biotechnologies
- Merck KgaA
- Solaris Biotechnology Srl
- Eppendorf AG
- Distek Inc.
- Celltainer Biotech BV
- ABEC Inc.
- Thermo Fisher Scientific
- Danaher Corporation (Pall Corporation)
